The role of GRP, as a neuropeptide in exerting a stimulatory effect on a complex regulatory network of inflammatory mediators and immune cells during periodontitis, is presumable, but understanding the neurogenic component of periodontal disease is challenging because changes in neuropeptide levels are only part of a cascade of chemical activity [21]. This evidence concerns the gene GRP and periodontal disorder.